Ion Channel Modulators
- VX661 [orb181347]
[1152311-62-0]
520.5
C26H27F3N2O6
C(C1=CC=C2OC(F)(F)OC2=C1)(C(NC1C(F)=CC2=C(C=1)C=C(C(C)(C)CO)N2C[C@H](O)CO)=O)1CC1
10 mM * 1 mL in DMSO, 100 mg, 250 mg, 1000 mg - Sodium-Channel-inhibitor-1 [orb181326]
[1198117-23-5]
473.42
C24H19F4N3O3
O=C(C1N(CCC2=NC=CC=C2)C(C3=C1C(F)=CC=C3)=O)NCC4=CC=C(OC(F)(F)F)C=C4
100 mg, 250 mg, 1000 mg - PPQ-102 [orb181305]
[931706-15-9]
438.48
C26H22N4O3
C12N3C(C4=CC=CC=C4)=C4C(=O)N(C)C(=O)N(C)C4=C3C(C3=CC=C(C)O3)NC=1C=CC=C2
10 mM * 1 mL in DMSO, 100 mg, 250 mg, 1000 mg - KU14R [orb181273]
[189224-48-4]
214.26
C13H14N2O
CCC1(C2=NC=CN2)OC3=CC=CC=C3C1
100 mg, 250 mg, 1000 mg - TAK-438 [orb181155]
[1260141-27-2]
461.46
C17H16FN3O2S.C4H4O4
N(S(C1=CC=CN=C1)(=O)=O)1C(C2=CC=CC=C2F)=CC(CNC)=C1.C(O)(=O)/C=C/C(O)=O
100 mg, 250 mg, 1000 mg - Ralfinamide [orb181142]
[202825-45-4]
398.44902
C17H19N2O2F.CH4O3S
C[C@H](NCC1=CC=C(OCC2=CC=CC=C2F)C=C1)C(N)=O.CS(=O)(O)=O
100 mg, 250 mg, 1 g - Rufinamide [orb181120]
[106308-44-5]
238.1935
C10H8F2N4O
NC(=O)C1=CN(N=N1)CC2=C(F)C=CC=C2F
100 mg, 250 mg, 1000 mg - ICILIN [orb181068]
[36945-98-9]
311.2921
C16H13N3O4
O=C1N([H])C(C2C([H])=C([H])C([H])=C(C=2[H])[N+](=O)[O-])=C([H])C([H])([H])N1C1=C([H])C([H])=C([H])C([H])=C1O[H]
100 mg, 250 mg, 1000 mg - IOWH-032 [orb181036]
[1191252-49-9]
545.18
C22H15Br2N3O4
BrC1=C(O)C(Br)=CC(C2=NOC(C(NCC3=CC=C(OC4=CC=CC=C4)C=C3)=O)=N2)=C1
100 mg, 250 mg, 1000 mg - 1 imageCFTRinh 172 [orb180957]
[307510-92-5]
409.4
C18H10F3NO3S2
C(O)(=O)C1=CC=C(/C=C2\SC(=S)N(C3=CC=CC(C(F)(F)F)=C3)C\2=O)C=C1
10 mM * 1 mL in DMSO, 100 mg, 250 mg, 1000 mg -
